Molecular cloning of the gyrA and gyrB genes of Bacteroides fragilis encoding DNA gyrase

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 10, 1999, Pages 2423-2429

  Onodera, Yoshikuni ^a   Sato, Kenichi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTEROIDES FRAGILIS; DNA SUPERCOILING; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

EID: 0032847095     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.10.2423     Document Type: Article

References (34)

1. Belland, R. J., S. G. Morrison, C. Ison, and W. H. Huang. 1994. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol. Microbiol. 14:371-380.
2. Breins, D. M., S. Ouadbesselam, E. Y. Ng, J. Tankovic, S. Shah, C. J. Soussy, and D. C. Hooper. 1997. Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. Antimicrob. Agents Chemother. 41:175-179.
3. Brown, P. O., and N. R. Cozzarelli. 1980. A sign inversion mechanism for enzymatic supercoiling of DNA. Science 206:1081-1083.
4. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
5. Cullen, M. E., A. W. Wyke, R. Kuroda, and L. M. Fisher. 1989. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. Antimicrob. Agents Chemother. 33:886-894.
6. Ferrero, L., B. Cameron, B. Manse, D. Lagneux, J. Crouzet, A. Famechon, and F. Blanche. 1994. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target for fluoroquinolones. Mol. Microbiol. 13:641-653.
7. Gallert, M., K. Mizuuchi, M. H. O'Dea, T. Itoh, and J. I. Tomizawa. 1977. Nalidixic acid resistance: a second character involved in DNA gyrase activity. Proc. Natl. Acad. Sci. USA 74:4772-4776.
8. Gellert, M., K. Mizuuchi, M. H. O'Dea, and H. A. Nash. 1977. DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc. Natl. Acad. Sci. USA 73:3872-3876.
9. Hecht, D. W., and H. M. Wexler. 1996. In vitro susceptibility of anaerobes to quinolones in the United States. Clin. Infect. Dis. 23:S2-S8.
10. Heisig, P., H. Schedletzky, and H. Falkenstein-Paul. 1993. Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 37:696-701.
11. Hill, G. B. 1992. Introduction to the anaerobic bacteria: non-spore-forming anaerobes, p. 621-635. In W. K. Joklik, H. P. Willett, D. B. Amos, and C. M. Willett (ed.), Zinsser microbiology, 20th ed. Appleton & Lange, Norwalk, Conn.
12. Horowitz, D. S., and J. C. Wang. 1987. Mapping the activity site tyrosine of Escherichia coli DNA gyrase. J. Biol. Chem. 269:5339-5344.
13. Hoshino, K., A. Akasaka, I. Morrissey, K. Sato, J. Kato, and H. Ikeda. 1994. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Antimicrob. Agents Chemother. 38:2623-2627.
14. Kato, J., Y. Nishimura, R. Imamura, H. Niki, S. Higara, and H. Suzuki. 1990. New topoisomerase essential for chromosome segregation in E. coli. Cell 63:393-404.
15. Khodursky, A. B., E. L. Zechiedrich, and N. R. Coizarelli. 1995. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. USA 92:11801-11805.
16. Kumagai, Y., J. Kato, K. Hoshino, T. Akasaka, K. Sato, and H. Ikeda. 1996. Quinolone-resistant mutants of Escherichia coli DNA topoisomerase IV parC gene. Antimicrob. Agents Chemother. 40:710-714.
17. Lewis, K. 1994. Multidrug resistance pumps in bacteria: variations on a theme. Trends Biochem. Sci. 19:119-123.
18. Li, X.-Z., D. M. Livermore, and H. Nikaido. 1994. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetiacycline, chloramphenicol, and norfloxacin. Antimicrob. Agents Chemother. 38:1732-1741.
19. Maniatis, T., R. F. Fritsch, and J. Sambrook. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
20. Miyamae, S., H. Nikaido, Y. Tanaka, and F. Yoshimura. 1998. Active efflux of norfloxacin by Bacteroides fragilis. Antimicrob. Agents Chemother. 42: 2119-2121.
21. Mizuuchi, K., L. M. Fisher, M. H. O'Dea, and M. Gallert. 1980. DNA gyrase action involves the introduction of transient double-strand DNA breaks into DNA. Proc. Natl. Acad. Sci. USA 77:1847-1851.
22. Nikaido, H. 1996. Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 178:5853-5859.
23. Oram, M., and L. M. Fisher. 1991. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob. Agents Chemother. 35:387-389.
24. Pan, X. S., and L. M. Fisher. 1996. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. J. Bacteriol. 178:4060-4069.
25. Pan, X. S., J. Ambler, S. Mehtar, and L. M. Fisher. 1996. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:2321-2326.
26. Piddock, L. J. V. 1995. Mechanism of resistance to fluoroquinolones: state-of-the-art 1992-1994. Drugs 49:29-35.
27. Rasmussen, B., K. Bush, and F. P. Tally. 1997. Antimicrobial resistance in anaerobes. Clin. Infect. Dis. 24:5110-5120.
28. Tanaka, M., K. Sato, Y. Kimura, I. Hayakawa, Y. Osada, and T. Nishino. 1991. Inhibition by quinolones of DNA gyrase from Staphylococcus aureus. Antimicrob. Agents Chemother. 35:1489-1491.
29. Tanaka, M., Y. Onodera, Y. Uchida, K. Sato, and I. Hayakawa. 1997. Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus. Antimicrob. Agents Chemother. 41: 2362-2366.
30. Tanaka, M., Y. Onodera, Y. Uchida, and K. Sato. 1998. Quinolone resistance mutation in the GrIB protein of Staphylococcus aureus. Antimicrob. Agents Chemother. 42:3044-3046.
31. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
32. Yoshida, H., M. Bogaki, S. Nakamura, K. Ubukata, and M. Kanno. 1990. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 172:6942-6949.
33. Yoshida, H., M. Bogaki, M. Nakamura, L. M. Yamanaka, and S. Nakamura. 1991. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35:1647-1650.
34. Yotsuji, A., J. Mitujama, R. Hori, T. Yasuda, I. Saikawa, M. Inoue, and S. Mitsubishi. 1988. Outer membrane permeation of B. fragilis by cephalosporins. Antimicrob. Agents Chemother. 32:1097-1099.